Bird Rock Bio, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: La Jolla CA United States (2002)
Status: Acquired by SkyePharma AG (2023)

Organization Overview

First Clinical Trial
2016
NCT02795299
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Bird Rock Bio, Inc.

Active Ingredients

Drugs in Phase 2 Trials (4)

folic acid (1 trial)

gerilimzumab (1 trial)

naltrexone (revia) (1 trial)

nimacimab (1 trial)

Drugs in Phase 1 Trials (1)

ryi-018 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Fatty Liver (Phase 1)

Gastroparesis (Phase 2)

Liver Diseases (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5